Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3404-3411
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3404
Table 4 Features of hepatocellular carcinoma patients based on the antiviral therapy status
VariablesHCC group on anti-viral therapy (n = 9)HCC group on no therapy (n = 4)
Mean age ± SD, yr53.2 ± 8.546.5 ± 20.5
Male: female7:22:2
HBeAg negative8/94/4
Undetectable HBV DNA8/90/4
Cirrhosis4/90/4
Invasive HCC3/94/4
Tumor:
Well differentiation6/91/4
Moderate differentiation3/93/4
Intrahepatic HBcAg staining
(+) Only in tumor tissues4/91/4
(+) Only in non-tumor tissues3/91/4
(+) Both in tumor and non-tumor tissues2/92/4
Intrahepatic HBsAg staining
(+) Only in tumor tissues1/90/4
(+) Only in non-tumor tissues3/92/4
(+) Both in tumor and non-tumor tissues3/91/4